The Food and Drug Administration began hearings Monday on the regulation and marketing of homeopathic products. Homeopathy is based on the notion that illnesses can be cured by highly diluted doses of the substance causing the illness. At issue is whether or not these remedies should go through a drug approval process similar to conventional treatments. Considered a pseudo-science by the medical establishment, patients and practitioners swear by the efficacy of homeopathy. We’ll get an update on the hearings and discuss whether or not the FDA should regulate homeopathic products.
FDA Considers Regulating Homeopathic Products
(Getty Images)
Guests:
Cynthia Schnedar, director of the Office of Compliance at the Center for Drug Evaluation and Research
Karen Allen, board member of the Integrative Health Policy Consortium
Adriane Fugh-Berman, associate professor of pharmacology at Georgetown University
Sponsored